ONY Biotech
Dr. Edmund Egan is a founder, Chairman and Chief Scientific Officer of ONY Biotech. Dr. Egan is also a professor of pediatrics (neonatology) and of physiology & biophysics at the State University of New York at Buffalo.
Dr. Egan led the successful animal research and one of the original trials in premature babies that proved that Infasurf® was an important, lifesaving therapy. His tenure at ONY Biotech spans its founding as ONY, Inc. to present.
This person is not in any offices
ONY Biotech
A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. They innovate with a singular purpose: to improve outcomes for premature babies and their families.